These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4131419)

  • 1. Fibrinolysis in patients on regular hemodialysis.
    Edward N
    Clin Nephrol; 1972; 1(2):97-100. PubMed ID: 4131419
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in fibrinolytic activity during the course of a single hemodialysis session.
    Kurz H; Lerner RG; Weseley S; Nelson JC
    Clin Nephrol; 1985 Jul; 24(1):1-4. PubMed ID: 4040447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin dissolution in synovial fluid.
    Andersen RB; Gormsen J
    Acta Rheumatol Scand; 1970; 16(4):319-33. PubMed ID: 4099587
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue plasminogen activator as a hemodialysis catheter locking solution.
    McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
    Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A; Kolarz M; Kopeć G; Tracz W
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rHuEPO increases urinary excretion of fibrin degradation products in haemodialysed patients.
    Gareau R; Gagnon MG; Ayotte C; Chénard C; Brisson GR
    Thromb Haemost; 1993 Aug; 70(2):373-4. PubMed ID: 8236152
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinous pericarditis and fibrinolysis in chronic dialysis patients.
    Cochran M; Lawton S; Rowlands LM
    Clin Nephrol; 1979 Jan; 11(1):23-5. PubMed ID: 428151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On coagulation and fibrinolysis in renal failure.
    Larsson SO
    Scand J Haematol Suppl; 1971; 15():1-59. PubMed ID: 5284430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolysis in hemodialyzed patients with chronic kidney failure].
    Kvasnicka J; Richter J; Brzák P; Bártová V
    Cas Lek Cesk; 1988 Jul; 127(29):912-5. PubMed ID: 3167960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolysis in chronic renal insufficiency treated wth periodic hemodialysis].
    Triolo R; Cavagnino A; Cavalli PL
    Minerva Med; 1972 Sep; 63(68):3704-12. PubMed ID: 5071959
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic activity in Nigerian diabetics with renal insufficiency.
    Unuigbe EI; Famodu AA; Umunna CE
    Clin Hemorheol Microcirc; 2005; 32(1):13-7. PubMed ID: 15665422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic activity in subacute endocarditis].
    Scrobohaci ML; Orha I; Stăncioiu N
    Thromb Diath Haemorrh; 1970 Dec; 24(3):512-21. PubMed ID: 4100817
    [No Abstract]   [Full Text] [Related]  

  • 20. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    Agarwal S; Joyner KA; Swaim MW
    Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.